E-LIB Suche - Ergebnisse für: Jacobson, C. A.

1

BISPECIFIC ANTI‐CD20/19 CAR‐T—ZAMTOCABTAGENE AUTOLEUCEL FOR..:

Ulrickson, M. ; Miklos, D. B. ; Maziarz, R. T...
Hematological Oncology. 41 (2023) S2 - p. 147-147 , 2023

Link: https://doi.org/10.1002/..

2

SALVAGE RADIOTHERAPY IN RELAPSED/REFRACTORY LARGE B‐CELL LY..:

Ababneh, H. S. ; Ng, A. K. ; Frigault, M. J....
Hematological Oncology. 41 (2023) S2 - p. 221-222 , 2023

Link: https://doi.org/10.1002/..

3

ZUMA‐23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF ..:

Westin, J. ; Jacobson, C. A. ; Chavez, J. C....
Hematological Oncology. 41 (2023) S2 - p. 171-173 , 2023

Link: https://doi.org/10.1002/..

4

Initial results of a multicenter phase 2 study of venetocla..:

Davids, M. S. ; Rogers, K. A. ; Jain, N....
Hematological Oncology. 41 (2023) S2 - p. 466-468 , 2023

Link: https://doi.org/10.1002/..

5

ZUMA‐22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTA..:

Flinn, I. W. ; Jacobson, C. A. ; Nastoupil, L. J....
Hematological Oncology. 41 (2023) S2 - p. 853-855 , 2023

Link: https://doi.org/10.1002/..

6

5‐YEAR (Y) FOLLOW‐UP OF A PHASE 2 STUDY OF IBRUTINIB PLUS F..:

Ahn, I. E. ; Brander, D. M. ; Ren, Y....
Hematological Oncology. 41 (2023) S2 - p. 231-233 , 2023

Link: https://doi.org/10.1002/..

7

PRIMARY OVERALL SURVIVAL ANALYSIS OF THE PHASE 3 RANDOMIZED..:

Westin, J. R. ; Oluwole, O. O. ; Kersten, M. J....
Hematological Oncology. 41 (2023) S2 - p. 52-54 , 2023

Link: https://doi.org/10.1002/..

8

Real‐World Early Outcomes of Axicabtagene Ciloleucel for Re..:

Jacobson, C. ; Hemmer, M. T. ; Hu, Z....
Hematological Oncology. 41 (2023) S2 - p. 375-376 , 2023

Link: https://doi.org/10.1002/..

9

Radiotherapy as a Bridging Approach in High-Grade B-Cell Ly..:

Ababneh, H. ; Jacobson, C. ; Frigault, M...
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. e352 , 2022

Link: https://doi.org/10.1016/..

10

CO152 Clinical Predictors of Axicabtagene Ciloleucel (AXI-C..:

Sanderson, R ; Munoz, J ; Wang, Y...
Value in Health. 25 (2022) 12 - p. S47-S48 , 2022

Link: https://doi.org/10.1016/..

11

Outcomes of Salvage Radiotherapy in Refractory or Relapsed ..:

Ababneh, H. ; Jacobson, C. ; Frigault, M...
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. S57 , 2022

Link: https://doi.org/10.1016/..

12

P1117: THREE-YEAR FOLLOW-UP OF OUTCOMES WITH KTE-X19 IN PAT..:

Wang, M. L. ; Munoz, J. ; Goy, A....
HemaSphere. 6 (2022) - p. 1007-1008 , 2022

Link: https://doi.org/10.1097/..

13

Seropositivity to Campylobacter and association with aborti..:

Clune, T ; Bruce, M ; Glanville, E...
Australian Veterinary Journal. 100 (2022) 8 - p. 397-406 , 2022

Link: https://doi.org/10.1111/..

14

S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 S..:

Sureda, A. ; Westin, J. ; Locke, F. L....
HemaSphere. 6 (2022) - p. 112-113 , 2022

Link: https://doi.org/10.1097/..

15

Linking aberrant pauses during object naming to letter and ..:

Carlsson, R. ; Svensson, I. ; Jacobson, C..
Nordic Psychology. 75 (2022) 3 - p. 213-226 , 2022

Link: https://doi.org/10.1080/..